Brain transplantation of neural stem cells cotransduced with tyrosine hydroxylase and GTP cyclohydrolase 1 in parkinsonian rats

Cell Transplantation

Volumn 14, Issue 4, 2005, Pages 193-202

  Ryu, M Y ^a   Lee, M A ^a   Ahn, Y H ^a   Kim, K S ^a,c   Yoon, S H ^a   Snyder, E Y ^b   Cho, K G ^a   Kim, S U ^a,c  

^a Ajou University School of Medicine   (South Korea)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Brain transplantation; C17.2 cell line; GTP cyclohydrolase 1; L DOPA; Neural stem cell; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; BRAIN TRANSPLANTATION; CELL MIGRATION; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENE THERAPY; GENE TRANSFER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL DIFFERENTIATION; NERVE GROWTH; NEURAL STEM CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; WESTERN BLOTTING;

PARKINSONIA;

EID: 18744381864     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000005783983133     Document Type: Conference Paper

References (40)

1. Aboody, K.; Brown, A.; Rainov, N. G.; Bower, K. A.; Liu, S.; Yang, W.; Small, J.; Herrlinger, U.; Ourednik, V.; Black, P. M.; Breakfield, X.; Snyder, E. Y. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc. Nat. Acad. Sci. USA 97:12846-12851; 2000.
2. Agid, Y. Parkinson's disease: Pathophysiology. Lancet 337:1321-1324; 1991.
3. Anton, R.; Kordower, J. H.; Maidment, N. T.; Manaster, J. S.; Kane, D. J.; Rabizadeh, S.; Schueller, S. B.; Yang, J.; Edards, R. H.; Markham, C. H.; Bredesen, D. E. Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Exp. Neurol. 127:207-218; 1994.
4. Bencsics, C.; Wachtel, S. R.; Milstien, S.; Hatakeyama, K.; Becker, J. B.; Kang, U. J. Double transduction with GTP cyclohydrolasel and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. J. Neurosci. 16:4449-4456; 1996.
5. Benedetti, S.; Pirola, B.; Pollo, B.; Magrassi, L.; Bruzzone, M. G.; Rigamonti, D.; Galli, R.; Selleri, S.; Di Meco, F.; De Fraja, C.; Vescovi, A.; Cattaneo, E.; Finocchiaro, G. Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6:447-450; 2000.
6. Björklund, A.; Lindvall, O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3:537-544; 2000.
7. Brüstle, O.; McKay, R. D. G. Neuronal progenitors as tools for cell replacement in the nervous system. Curr. Opin. Neurobiol. 6:688-695; 1996.
8. Duan, W.; Widner, H.; Brundin, P. Temporal pattern of host responses against intrastriatal grafts of syngenic, allogenic or xenogenic embryonic neuronal tissue in rats. Exp. Brain Res. 104:227-242; 2000.
9. During, M. J.; Naegele, J. R.; O'Malley, K. L.; Geller, A. I. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399-1403; 1991.
10. Fisher, L. J.; Jinnah, H. A.; Kale, L. C.; Higgins, G. A.; Gage, F. H. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-DOPA. Neuron 6:371-380; 1991.
11. Fitoussi, N.; Sotnik-Barkai, I.; Tornatore, C.; Herzberg, U.; Yadid, G. Dopamine turnover and metabolism in the striatum of parkinsonian rats grafted with genetically modified human astrocytes. Neuroscience 85:405-413; 1998.
12. Flax, J. D.; Aurora, S.; Yang, C.; Simonin, C.; Wills, A. M.; Billinghurst, L. L.; Jendoubi, M.; Sidman, R. L.; Wolfe, J. H.; Kim, S. U.; Snyder, E. Y. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16: 1033-1039; 1998.
13. Gage, F. H. Mammalian neural stem cells. Science 287:1433-1438; 2000.
14. Gray, J. A.; Hodges, H.; Sinden, J. Prospects for the clinical application of neural transplantation with the use of conditionally immortalized neuroepithelial stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354:1407-1421; 1999.
15. Hatakeyama, K.; Inoue, Y.; Harada, T.; Kagamiyama, H. Cloning and sequencing of cDNA encoding rat GTP cyclohydrolase I. The first enzyme of the tetrahydrobiopterin biosynthetic pathway. J. Biol. Chem. 266:765-769; 1991.
16. Horellou, P.; Brundin, P.; Kalen, P.; Mallet, J.; Björklund, A. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5:393-402; 1990.
17. Kaplitt, M. G.; Leone, P.; Samulski, R. J.; Xiao, X.; Pfaff, D. W.; O'Malley, K. L.; During, M. J. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8:148-154; 1994.
18. Kish, S. J.; Shannak, K.; Hornykiewicz, O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N. Engl. J. Med. 318:876-880; 1988.
19. Kukekov, V. G.; Laywell, E. D.; Suslov, O.; Davies, K.; Scheffler, B.; Thomas, L. B.; O'Brien, T. F.; Kusakabe, M.; Steindler, D. A. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp. Neurol. 156:333-344; 1999.
20. Leff, S. E.; Rendahl, K. G.; Spratt, S. K.; Kang, U. J.; Mandel, R. J. In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTP cyclohydrolasel with tyrosine hydroxylase. Exp. Neurol. 151:249-264; 1998.
21. Levine, R. A.; Miller, L. P.; Lovenberg, W. Tetrahydrobiopterin in striatum: Localization in dopamine nerve terminals and role in catecholamine synthesis. Science 213:349-350; 1981.
22. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavil, B.; Leenders, K.; Sawle, G.; Rothwell, J.; Marsden, C. Grafts of fetal dopamine neurons survive and improve motor function in Parkinso's disease. Science 247:574-577; 1990.
23. Liu, Y.; Himes, B. T.; Solowska, J.; Chow, S. Y.; Park, K. I.; Tessler, A.; Murray, M.; Snyder, E. Y.; Fischer, I. Intraspinal delivery of neurotrophin-3 using neural stem cells genetically modified by recombinant retrovirus. Exp. Neurol. 158:9-26; 1999.
24. Lotharius, J.; Brundin, P. Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3:932-942; 2002.
25. Lundberg, C.; Horellou, P.; Mallet, J.; Björklund, A. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: In vitro and in vivo effects in the rat parkinson model. Exp. Neurol. 139:39-53; 1996.
26. Martinez-Serrano, A.; Björklund, A. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci. 20:530-538; 1997.
27. Mckay, R. Stem cell in the nervous system. Science 276:66-71; 1997.
28. Miller, A. D.; Miller, D. G.; Garcia, J. V.; Lynch, C. M. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217:581-599; 1993.
29. Morgenstern, J. P.; Land, H. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596; 1990.
30. Nagatsu, T. Biopterin cofactor and monoamine-synthesizing monooxygenases. Neurochem. Int. 5:27-38; 1983.
31. Nagatsu, T.; Levitt, M.; Udenfriend, S. Tyrosine hydroxylase. J. Biol. Chem. 239:2910-2917; 1964.
32. Nichol, C. A.; Smith, G. K.; Duch, D. S. Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin. Annu. Rev. Biochem. 54:729-764; 1985.
33. Olanow, C. W.; Kordower, J.; Freeman, T. Fetal nigral transplantation as a therapy for Parkinsons disease. Trends Neurosci. 19:102-109; 1996.
34. Owens, G. C.; Johnson, R.; Bunge, R. P.; O'Malley, K. L. Dihydroxyphenylalanine synthesis by genetically modified Schwann cells. J. Neurochem. 56:-1030-1036; 1991.
35. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates, 2nd ed. San Diego: Academic Press; 1986.
36. Raymon, H. K.; Thode, S.; Gage, F. H. Application of ex vivo gene therapy in the treatment of Parkinson's disease. Exp. Neurol. 144:82-91; 1997.
37. Rosario, C. M.; Yandava, B. D.; Kosaras, B.; Zurakowski, D.; Sidman, R. L.; Snyder, E. Y. Differentiation of engrafted multipotent neural progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action. Development 124:4213-4224; 1997.
38. Ryder, E. F.; Snyder, E. Y.; Cepko, C. L. Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. J. Neurobiol. 21:356-375; 1990.
39. Snyder, E. Y.; Deitcher, D. L.; Walsh, C.; Arnold-Aldea, S.; Hartwieg, E. A.; Cepko, C. L. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68:33-51; 1992.
40. Yandava, B. D.; Billinghurst, L.; Snyder, E. Y. "Global" cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc. Natl. Acad. Sci. USA 96:7029-7034; 1999.